Huffington Post: Narcolepsy Remains Misunderstood and Underdiagnosed

July 20, 2012

Do you have narcolepsy? NeuroTrials Research and Atlanta School of Sleep Medicine CEO Dr. Russell Rosenberg discusses the misconceptions of narcolepsy that lead to underdiagnosis in his new article with the Huffington Post:

Narcolepsy usually begins in the teens or early 20s, and all of the symptoms do not emerge simultaneously. AWAKEN, an online survey conducted by Harris Interactive and sponsored by Jazz Pharmaceuticals, surveyed 1,000 adults from the general public, 300 primary care physicians, and 100 sleep specialists. The results found that symptoms associated with narcolepsy are not clearly recognized or understood, which may contribute to under or misdiagnosis of the disorder. 

Read full article.

Follow all Dr. Rosenberg’s posts.


NeuroTrials Conducting New RLS Research

July 18, 2012

More than 5 million Americans have been diagnosed with RLS and as many as 1 in 10 adults will experience symptoms of RLS in their lifetime. Atlanta-based NeuroTrials Research is currently conducting a clinical research study of an investigational medication to treat Restless Legs Syndrome (RLS).

The primary symptom of RLS is an irresistible urge to move limbs in order to relieve uncomfortable sensations which can be severe at times. While the disorder most commonly affects legs, it can also be experienced in the arms or torso. The constant need to move causes difficulty falling asleep or patterns of interrupted and restless sleep. Common symptoms include:

  • Creepy crawly sensations in the legs or arms, especially when at rest
  • Uncomfortable sensations may be relieved by rubbing or moving around
  • Discomfort begins in the early evening and intensifies as bedtime approaches

Currently, NeuroTrials is evaluating a medication for the treatment of RLS that is already approved as a treatment for pain in Europe. If approved, this drug may be an alternative to some of the existing medications that carry varying levels of side effects.

“RLS is an underdiagnosed condition for which we need better options and we are excited to continue moving RLS research forward,” said Dr. Michael Lacey, Lead Investigator of the study at NeuroTrials, “RLS does not discriminate – it can begin at any age – and current treatment options come with a variety of side effects.”

Nationally recognized physicians and researchers founded NeuroTrials over a decade ago. NeuroTrials continues to attract important Phase I-IV studies that impact the health and welfare of residents in Atlanta and nationwide.

NeuroTrials is currently enrolling participants for this study. Patients who are 18-70 with a history of RLS for over 6 months, can contact NeuroTrials at 404-851-9934 for more information. Qualified study participants receive free medical evaluations, treatment and are compensated for their time and travel.  For full study details, visit www.neurotrials.com/studies.aspx.

Interested participants can also follow NeuroTrials on Facebook (facebook.com/neurotrials) and Twitter (twitter.com/neurotrials) for real-time updates on all enrolling studies.